U.S. markets closed

Athenex, Inc. (ATNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.5000-0.0600 (-1.69%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close3.5600
Open3.4500
Bid3.4800 x 1100
Ask3.5800 x 4000
Day's Range3.4300 - 3.6500
52 Week Range3.1200 - 15.0000
Volume11,050,638
Avg. Volume1,372,268
Market Cap382.578M
Beta (5Y Monthly)0.59
PE Ratio (TTM)N/A
EPS (TTM)-1.5570
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Athenex, Inc.
    CYTK: Raising target price to $35.00CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more